Fedders H, Alsadeq A, Schmäh J, Vogiatzi F, Zimmermann M, Möricke A, Lenk L, Stadt U zur, Horstmann MA, Pieters R, Schrappe M, Stanulla M, Cario G, Schewe DM. The role of constitutive activation of FMS-related tyrosine kinase-3 and NRas/KRas mutational status in infants with KMT2A-rearranged acute lymphoblastic leukemia. Haematologica 2017; 102(11):e438-e442; https://doi.org/10.3324/haematol.2017.169870.